We are live on
!
Find out more
ENZY
Enzymotec Ltd
ENZY
ENZY
Delisted
ENZY was delisted on the 10th of January, 2018.
18 hedge funds and large institutions have $67.7M invested in Enzymotec Ltd in 2015 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
17% more capital invested
Capital invested by funds: $57.8M → $67.7M (+$9.89M)
10% less funds holding
Funds holding: 20 → 18 (-2)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
18
Holders Change
-2
Holders Change %
-10%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$5.85M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$918K |
| 3 |
VAM
Visium Asset Management
New York
|
+$367K |
| 4 |
Renaissance Technologies
New York
|
+$260K |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$206K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$7.19M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$628K |
| 3 |
Millennium Management
New York
|
-$193K |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$112K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$78K |
